This guideline covers care and treatment for adults (aged 18 and over) with type 1 diabetes. It includes advice on diagnosis, education and support, blood glucose management, cardiovascular risk, and identifying and managing long-term complications.
In June 2022, we reviewed the evidence and made new re...
Clinical question What are the benefits and harms of sodium-glucose cotransporter 2 (SGLT-2) inhibitors and glucagon-like peptide 1 (GLP-1) receptor agonists when added to usual care (lifestyle interventions and/or other diabetes drugs) in adults with type 2 diabetes at different risk for cardiovascular ...
DESCRIPTION: In April 2017, the U.S. Department of Veterans Affairs (VA) and the U.S. Department of Defense (DoD) approved a joint clinical practice guideline for the management of type 2 diabetes mellitus. METHODS: The VA/DoD Evidence-Based Practice Work Group convened a joint VA/DoD guideline developme...
Diabète de type 2,
Diabète,
Marqueurs biologiques/sang,
Glycémie/métabolisme,
Angiopathies diabétiques/prévention et contrôle,
Fructosamine/sang,
Hémoglobine glyquée/métabolisme,
Hypoglycémiants/usage thérapeutique,
Espérance de vie,
Préférence des patients,
Soins centrés sur le patient,
Hémoglobine glyquée,
Hypoglycémiants
"OBJECTIVE:
To formulate clinical practice guidelines for the use of continuous glucose monitoring and continuous subcutaneous insulin infusion in adults with diabetes.
PARTICIPANTS:
The participants include an Endocrine Society-appointed Task Force of seven experts, a methodologist, and a medical write...
Glycémie,
Association thérapeutique,
Diabète de type 1,
Diabète de type 2,
Régime pour diabétique,
Surveillance des médicaments,
Endocrinologie,
Hyperglycémie,
Hypoglycémie,
Insuline/usage thérapeutique,
Pompes à insuline,
Surveillance électronique ambulatoire,
Éducation du patient comme sujet,
Médecine de précision,
Diabète de type 1/traitement médicamenteux,
Diabète de type 2/traitement médicamenteux,
Diabète de type 1/thérapie,
Diabète de type 2/thérapie,
Hypoglycémiants/usage thérapeutique,
Hypoglycémiants/effets indésirables,
Insuline/effets indésirables
Criteria for classifying and diagnosing hyperglycaemia first detected during pregnancy have been accepted by a group of experts convened by WHO. These new criteria are an update of recommendations published by WHO in 1999....
